SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the knee
16 references·1 citing·42 second hop
Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the knee (2017)Cost-effectiveness of adjunct non-pharmac…Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold (2015)Methods for the estimation of…Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database (2013)Review of studies mapping fro…Mapping to Obtain EQ-5D Utility Values for Use in NICE Health Technology Assessments (2013)Mapping to Obtain EQ-5D Utili…Evidence Synthesis for Decision Making 3 (2013)Evidence Synthesis for Decisi…Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development (2012)Informing a decision framewor…The Cochrane Collaboration's tool for assessing risk of bias in randomised trials (2011)The Cochrane Collaboration's …Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1 (2011)Interpreting Indirect Treatme…The importance of allocation concealment and patient blinding in osteoarthritis trials: A meta‐epidemiologic study (2009)The importance of allocation …Mapping SF-36 onto the EQ-5D index: how reliable is the relationship? (2009)Mapping SF-36 onto the EQ-5D …Estimating the Association between SF-12 Responses and EQ-5D Utility Values by Response Mapping (2006)Estimating the Association be…Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the Economic Eval…Combination of direct and indirect evidence in mixed treatment comparisons (2004)Combination of direct and ind…The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies (1999)The irrelevance of inference:…The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials (1997)The results of direct and ind…EuroQol: the current state of play (1996)EuroQol: the current state of…Methods for the economic evaluation of health care programmes (1987)Methods for the economic eval…A bibliometric analysis of traditional Chinese non-pharmacological therapies in the treatment of knee osteoarthritis from 2012 to 2022 (2023)A bibliometric analysis of tr…The PHQ-9 (2001)A Brief Measure for Assessing Generalized Anxiety Disorder (2006)Cost–effectiveness thresholds: pros and cons (2016)The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought (2016)Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries (2017)Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials (1995)GRADE guidelines: 8. Rating the quality of evidence—indirectness (2011)Indirect and mixed‐treatment comparison, network, or multiple‐treatments meta‐analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool (2012)CINeMA: An approach for assessing confidence in the results of a network meta-analysis (2020)EuroQol - a new facility for the measurement of health-related quality of life (1990)EQ-SD: a measure of health status from the EuroQol Group (2001)Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) (2011)Decision Analysis: Introductory Lectures on Choices Under Uncertainty. (1969)Regret Theory: An Alternative Theory of Rational Choice Under Uncertainty (1982)Net Health Benefits (1998)Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. (2008)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Cochrane Handbook for Systematic Reviews of Interventions (2008)QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies (2011)ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions (2016)RoB 2: a revised tool for assessing risk of bias in randomised trials (2019)10.1007/978-1-4899-4485-6 (2000)Checking consistency in mixed treatment comparison meta‐analysis (2010)Graphical Tools for Network Meta-Analysis in STATA (2013)ROBIS: A new tool to assess risk of bias in systematic reviews was developed (2015)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Conducting Indirect-Treatment-Comparison and Network-Meta-Analysis Studies: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 2 (2011)Conceptual and Technical Challenges in Network Meta-analysis (2013)Demystifying trial networks and network meta-analysis (2013)Introduction to Meta‐Analysis (2009)Network Meta-Analysis Using R: A Review of Currently Available Automated Packages (2014)Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: A systematic review and network meta-analysis (2015)GetReal in network meta‐analysis: a review of the methodology (2016)Introduction to Meta‐Analysis (2021)The estimation of a preference-based measure of health from the SF-36 (2002)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Measurement of health state utilities for economic appraisal (1986)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)The Estimation of a Preference-Based Measure of Health From the SF-12 (2004)
this work references cited by second hop

References

  • 2011The Cochrane Collaboration's tool for assessing risk of bias in randomised trials33,776 cited
  • 2005Methods for the Economic Evaluation of Health Care Programmes13,647 cited
  • 1996EuroQol: the current state of play5,812 cited
  • 1987Methods for the economic evaluation of health care programmes4,274 cited
  • 2004Combination of direct and indirect evidence in mixed treatment comparisons2,168 cited
  • 1997The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials2,052 cited
  • 2011Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 11,036 cited
  • 1999The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies891 cited
  • 2015Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold857 cited
  • 2013Evidence Synthesis for Decision Making 3468 cited
  • 2013Mapping to Obtain EQ-5D Utility Values for Use in NICE Health Technology Assessments263 cited
  • 2006Estimating the Association between SF-12 Responses and EQ-5D Utility Values by Response Mapping223 cited
  • 2009Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?191 cited
  • 2013

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database
153 cited
  • 2009The importance of allocation concealment and patient blinding in osteoarthritis trials: A meta‐epidemiologic study150 cited
  • 2012Informing a decision framework for when NICE should recommend the use of health technologies only in the context of an appropriately designed programme of evidence development119 cited
  • Cited by

    • 2023A bibliometric analysis of traditional Chinese non-pharmacological therapies in the treatment of knee osteoarthritis from 2012 to 202211 cited